期刊文献+

人甲状旁腺素(1-34)对新生Wistar大鼠心肌成纤维细胞增殖及胶原合成的影响

The Effects of Parathyroid Hormone on Proliferation and Collagen Synthesis of Rat Cardiac Fibroblasts
下载PDF
导出
摘要 目的:研究外源性人甲状旁腺素(1-34)hPTH(1-34)对原代培养新生Wistar鼠心肌成纤维细胞(CFs)增殖及胶原合成的影响。方法:分离、培养Wistar乳鼠心肌成纤维细胞,加入不同浓度的hPTH(1-34)共培养,四氮唑盐比色法(MTT)、3H-TdR掺入法检测细胞增殖;3H-Proline掺入法测定胶原合成。结果:随着一定浓度hPTH(1-34)的升高,CFs MTT法A490值及3H-TdR的掺入量、3H-脯氨酸掺入率呈明显的递增趋势(P<0.01);维拉帕米预处理组与单独应用组10-8mol/L hPTH相比,以上指标均显著降低(P<0.01)。结论:PTH可显著刺激成纤维细胞增殖及胶原合成,L型钙通道开放引起的细胞外钙内流增加为其重要机制之一。 Objective:To investigate the effects of parathyroid hormone (PTH) on proliferation and collagen synthesis of rat cardiac fibroblasts (CFs), Methods:Isolated and cultured CFs of Wistar rats were cultured with PTH. CFs proliferation was measured by MTT assay, The DNA synthesis of CFs was measured by 3 H - TdR uptake test. Collagen synthesis was measured by 3 H - Proline incorporation. Results:A490 value of CFs by MTT assay , CFs proliferation and the synthesis of collagen increased graduately with the elevation of hPTH concentrations was enhanced remarkably by constantly action of different concentration of hPTH(1-34) incubation(P〈 0.01); Compared to the group in which 10^-8mol/L hPTH was used separatdy, group pretreated with 10^-5mol/L verepamilshowed a significant decrease in index above(P〈 0.01 ). Conclusion: PTH dose - dependently increased DNA and collagen synthesis of CFs, partly due to augmented entry of calcium into call via voltage - dependent Ca^2 + channel.
出处 《中国中西医结合肾病杂志》 2006年第10期564-566,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 黑龙江省卫生厅基金资助项目(No.2005-263) 哈尔滨医科大学附属第二医院青年基金资助项目(No.2005-13)
关键词 甲状旁腺素(1-34) 心肌 成纤维细胞 大鼠 Parathyroid hormone(1 - 34) ,Cardiac ,Fibroblasts, Rats
  • 相关文献

参考文献8

  • 1Tyralla K,Amann K.Morphology of the heart and arteries in renal failure.Kidney Int Suppl,2003,(84):S80-S83.
  • 2Tyralla K,Amann K.Cardiovascular changes in renal failure.Blood Purif,2002,20(5):462-465.
  • 3Mall G,Huther W,Schneider J,et al.Diffuse intermyocardiocytic fibrosis in uraemic patients.Nephrol Dial Transplant.Nephrol Dial Transplant,1990,5(1):39-44.
  • 4Menon V,Sarnak MJ.Treating the Patient with Kidney Failure to Reduce Cardiovascular Disease Risk.Curr Treat Options Cardiovasc Med,2004,6(4):257-268.
  • 5Coladonato JA,Ritz E.Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patients.Adv Ren Replace Ther,2002,9(3):193-199.
  • 6Schluter KD,Piper HM.Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.Cardiovasc Res,1998,37(1):34-41.
  • 7Amann K,Kronenberg G,Gehlen F,et al.Cardiac remodelling in experimental renal failure--an immunohistochemical study.Nephrol Dial Transplant,1998,13(8):1958-1966.
  • 8Spedding M,Paoletti R.Classification of calcium channel and the sites of action of drugs modifying channel function.Pharmacol Rew,1992,44(3):363-376.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部